Adipose tissue-derived stem cells for veterinary use
AssigneeCell4Vet Corporation
InventorsChing Shwun LIN, Tom F. LUE, Guiting LIN
Life of this patent
Estimating the term…
Abstract
The invention provides for compositions and methods for making and using adipose-derived stem cells for treating non-human mammals for various medical conditions.
Claims17
A method of treating a medical condition in a non-human mammal in need thereof comprising administering to the non-human mammal an effective amount of a purified population of porcine adipose tissue-derived stem cells (ADSC),
- wherein the medical condition is one or more condition selected from the group consisting of:
- degenerative myelopathy, diabetes, tissue regeneration, wound healing, scarring, soft tissue defect, fecal incontinence, dilated cardiomyopathy, hip dysplasia, avascular necrosis of the femoral head, ligament injury, tendon injury, spinal cord injury, atherosclerosis-related infarctions, muscular dystrophy, pain, and inflammation, and
- wherein the ADSC are xenogenic to the non-human mammal.
A bank of porcine ADSC for use in treatment of a medical condition wherein the ADSC is xenogeneic to the recipient of the ADSC and wherein the medical condition is one or more condition selected from the group consisting of:
- degenerative myelopathy, diabetes, tissue regeneration, wound healing, scarring, soft tissue defect, fecal incontinence, dilated cardiomyopathy, hip dysplasia, avascular necrosis of the femoral head, ligament injury, tendon injury, spinal cord injury, atherosclerosis-related infarctions, muscular dystrophy, inflammation and pain.
A composition comprising a purified population of porcine ADSC and CMC for use in xenotransplantation.
Dependencies are inferred from the claim text.